Stay updated on PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Sign up to get notified when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updates include new registry identifiers, a new document version (v3.0.2), clearer timing for the last update, and migration of access materials to new URLs, replacing older EngageZone links.
    Difference
    2%
    Check dated 2025-09-14T21:51:57.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T18:47:47.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of various facility names and locations across multiple countries, while also removing outdated location references and some medical topics. Notably, the revision number has been updated to v3.0.0.
    Difference
    8%
    Check dated 2025-08-31T12:20:18.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:45:24.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-10T00:38:24.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T19:34:50.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Clinical Trial: Pembrolizumab Combo page.